BIOCRYST PHARMACEUTICALS, INC. Employee Count
The employee counts BIOCRYST PHARMACEUTICALS, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 435; Filing 2026-02-26; Lease expense per employee $5,606.90.
- 2024-12-31: Employees (as filed) 580; Filing 2025-02-25; Lease expense per employee $3,589.66.
- 2023-12-31: Employees (as filed) 536; Filing 2024-02-27; Lease expense per employee $2,636.19.
- 2022-12-31: Employees (as filed) 531; Filing 2023-02-27; Lease expense per employee $1,796.61.
- Available history
- 2018-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 435 | 2026-02-26 | $5,606.90 finance amortization + finance interest |
| 2024-12-31 | 580 | 2025-02-25 | $3,589.66 finance amortization + finance interest |
| 2023-12-31 | 536 | 2024-02-27 | $2,636.19 finance amortization + finance interest |
| 2022-12-31 | 531 | 2023-02-27 | $1,796.61 finance amortization + finance interest |
| 2021-12-31 | 358 | 2022-02-28 | $377.09 finance amortization + finance interest |
| 2020-12-31 | 246 | 2021-03-01 | |
| 2019-12-31 | 140 | 2020-03-13 | |
| 2018-12-31 | 100 | 2019-03-14 | $7,580.00 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |